RPM Report Interview with Ellen Sigal | Friends of Cancer Research

You are here

RPM Report Interview with Ellen Sigal

FDA and Cancer Drug Development: An Advocate’s View

Friends of Cancer Research (www.focr.org) has been among the most vocal supporters of a robust FDA review process for oncology drugs. Chair & Founder Dr. Ellen Sigal has taken the advocacy group from a one-person shop to an organization with strong ties to the agency and the lawmakers on Capitol Hill who matter most to the future of cancer treatment.